MeritValue

Odyssey Health, Inc.

ODYYdata completeness 63%11 fiscal years on file

Data notes: no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'; no data for concept 'pretaxIncome'

i. The business — what you’d actually own
FigureFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue—————
Net income−$16.9M1−$8.44M2−$5.92M3−$842,3164−$1.74M4
Operating cash flow−$3.18M5−$1.47M5−$1.47M6−$1.22M7−$347,3927
Capital expenditure—————
Free cash flow (derived)—————
Total debt$08$1.18M9———
Cash & equivalents$556,58410$72,53411$36,86512$2,37913$19,08413
Diluted shares93.7M89.0M82.7M97.1M104.7M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.66
your share of equity
Profit it earned you last year
−$0.17
Free cash flow it threw off
—
Debt you’d be carrying
—

10 shares is a claim on −$0.66 of net worth that earned you −$0.17 last year.

iii. Is this a good business?
Moat signal · return on equity
— avg · 5y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
+12% shares · 5y

Share count is up 12% over 5 years — owners have been diluted. Worth asking what they got for it.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.5.0
DCF · Growth Exit 10Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2021-07-31 · accession 0001683168-22-007161 (NetIncomeLoss)
  2. 10-K · period ending 2022-07-31 · accession 0001683168-23-007508 (NetIncomeLoss)
  3. 10-K · period ending 2023-07-31 · accession 0001683168-24-007967 (NetIncomeLoss)
  4. 10-K · period ending 2024-07-31 · accession 0001683168-25-007842 (NetIncomeLoss)
  5. 10-K · period ending 2021-07-31 · accession 0001683168-23-007508 (NetCashProvidedByUsedInOperatingActivities)
  6. 10-K · period ending 2023-07-31 · accession 0001683168-24-007967 (NetCashProvidedByUsedInOperatingActivities)
  7. 10-K · period ending 2024-07-31 · accession 0001683168-25-007842 (NetCashProvidedByUsedInOperatingActivities)
  8. 10-K · period ending 2021-07-31 · accession 0001683168-21-005136 (LongTermDebt)
  9. 10-K · period ending 2022-07-31 · accession 0001683168-22-007161 (DebtCurrent)
  10. 10-K · period ending 2021-07-31 · accession 0001683168-21-005136 (CashAndCashEquivalentsAtCarryingValue)
  11. 10-K · period ending 2022-07-31 · accession 0001683168-22-007161 (CashAndCashEquivalentsAtCarryingValue)
  12. 10-K · period ending 2023-07-31 · accession 0001683168-23-007508 (CashAndCashEquivalentsAtCarryingValue)
  13. 10-K · period ending 2024-07-31 · accession 0001683168-25-007842 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)